These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25823858)

  • 21. Cystic Fibrosis Lung Immunity: The Role of the Macrophage.
    Bruscia EM; Bonfield TL
    J Innate Immun; 2016; 8(6):550-563. PubMed ID: 27336915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airway mucus in cystic fibrosis.
    Puchelle E; Bajolet O; Abély M
    Paediatr Respir Rev; 2002 Jun; 3(2):115-9. PubMed ID: 12297057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
    Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
    Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis.
    Siegmann N; Worbs D; Effinger F; Bormann T; Gebhardt M; Ulrich M; Wermeling F; Müller-Hermelink E; Biedermann T; Tighe M; Edwards MJ; Caldwell C; Leadbetter E; Karlsson MC; Becker KA; Gulbins E; Döring G
    Cell Physiol Biochem; 2014; 34(1):56-70. PubMed ID: 24977481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's new in CF airway inflammation: an update.
    Ratjen F
    Paediatr Respir Rev; 2006; 7 Suppl 1():S70-2. PubMed ID: 16798601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis.
    Venkatakrishnan V; Packer NH; Thaysen-Andersen M
    Expert Rev Respir Med; 2013 Oct; 7(5):553-76. PubMed ID: 24138697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
    Regamey N; Tsartsali L; Hilliard TN; Fuchs O; Tan HL; Zhu J; Qiu YS; Alton EW; Jeffery PK; Bush A; Davies JC
    Thorax; 2012 Feb; 67(2):164-70. PubMed ID: 22008188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
    Cohen-Cymberknoh M; Kerem E; Ferkol T; Elizur A
    Thorax; 2013 Dec; 68(12):1157-62. PubMed ID: 23704228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of airway surface liquid pH on host defense in cystic fibrosis.
    Berkebile AR; McCray PB
    Int J Biochem Cell Biol; 2014 Jul; 52():124-9. PubMed ID: 24560894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
    Deschemin JC; Allouche S; Brouillard F; Vaulont S
    PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator.
    Tirkos S; Newbigging S; Nguyen V; Keet M; Ackerley C; Kent G; Rozmahel RF
    Respir Res; 2006 Mar; 7(1):51. PubMed ID: 16571124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental paradigm for early features of cystic fibrosis.
    Larson JE; Cohen JC
    Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis.
    Philippe R; Urbach V
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.
    Hisert KB; Heltshe SL; Pope C; Jorth P; Wu X; Edwards RM; Radey M; Accurso FJ; Wolter DJ; Cooke G; Adam RJ; Carter S; Grogan B; Launspach JL; Donnelly SC; Gallagher CG; Bruce JE; Stoltz DA; Welsh MJ; Hoffman LR; McKone EF; Singh PK
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1617-1628. PubMed ID: 28222269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis.
    Nagy B; Nagy B; Fila L; Clarke LA; Gönczy F; Bede O; Nagy D; Újhelyi R; Szabó Á; Anghelyi A; Major M; Bene Z; Fejes Z; Antal-Szalmás P; Bhattoa HP; Balla G; Kappelmayer J; Amaral MD; Macek M; Balogh I
    Chest; 2016 Sep; 150(3):661-72. PubMed ID: 27105680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
    Jiang Q; Engelhardt JF
    Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Airway epithelial cells--hyperabsorption in CF?
    Kunzelmann K; Schreiber R
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1232-5. PubMed ID: 22542896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation.
    Buchanan PJ; Ernst RK; Elborn JS; Schock B
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):863-7. PubMed ID: 19614608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress modulates the expression of genes involved in cell survival in ΔF508 cystic fibrosis airway epithelial cells.
    Voisin G; Bouvet GF; Legendre P; Dagenais A; Massé C; Berthiaume Y
    Physiol Genomics; 2014 Sep; 46(17):634-46. PubMed ID: 24893876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.